In the last trading session, 1.39 million shares of the I-Mab ADR (NASDAQ:IMAB) were traded, and its beta was 1.20. Most recently the company’s share price was $0.96, and it changed around $0.29 or 42.81% from the last close, which brings the market valuation of the company to $75.14M. IMAB currently trades at a discount to its 52-week high of $2.00, offering almost -108.33% off that amount. The share price’s 52-week low was $0.60, which indicates that the current value has risen by an impressive 37.5% since then. We note from I-Mab ADR’s average daily trading volume that its 10-day average is 0.41 million shares, with the 3-month average coming to 252.69K.

I-Mab ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended IMAB as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. I-Mab ADR is expected to report earnings per share of -0.06 for the current quarter.

I-Mab ADR (NASDAQ:IMAB) trade information

Instantly IMAB has showed a green trend with a performance of 42.81% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.0091 on recent trading dayincreased the stock’s daily price by 4.87%. The company’s shares are currently up 12.44% year-to-date, but still up 54.15% over the last five days. On the other hand, I-Mab ADR (NASDAQ:IMAB) is 13.78% up in the 30-day period. We can see from the shorts that 0.33 million shares have been sold at a short interest cover period of 1.53 day(s).

Forecasts for the next quarter put sales growth at 0.00%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 28.36%.

IMAB Dividends

I-Mab ADR’s next quarterly earnings report is expected to be released on 2023-Aug-16.

I-Mab ADR (NASDAQ:IMAB)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 11.08% of I-Mab ADR shares, and 33.06% of them are in the hands of institutional investors. The stock currently has a share float of 37.18%. I-Mab ADR stock is held by 32.0 institutions, with HHLR ADVISORS, LTD. being the largest institutional investor. By 2024-06-30, it held 7.7935% of the shares, which is about 6.91 million shares worth $11.54 million.

CALIGAN PARTNERS LP, with 3.8067% or 3.37 million shares worth $5.64 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

abrdn Healthcare Investors and abrdn Healthcare Opportunities Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 53.88 shares worth $51497.0, making up 0.07% of all outstanding shares. On the other hand, abrdn Healthcare Opportunities Fund held roughly 43.74 shares worth around $41800.0, which represents about 0.05% of the total shares outstanding.